查詢結果分析
相關文獻
- In Vitro Activity of Rifabutin and Rifampin Against Clinical Isolates of Mycobacterium Tuberculosis in Taiwan
- Drug Resistance Patterns of Tuberculosis in Taiwan
- X-Linked Recessive Bulbospinal Neuronopathy: Clinical and Molecular Studies in a Taiwanese Family
- Dideoxy Fingerprinting for Rapid Screening of RpoB Gene Mutations in Clinical Isolates of Mycobacterium Tuberculosis
- 臺灣五十年來臨床醫學繼續教育之發展
- 臺灣白鼻心(Paguma larvata taivana)例行性臨床檢查之參考值
- 一篇診斷日治時代臺灣社會病症的政治文獻--蔣渭水「臨床講義」探析
- Quality Assurance in Clinical Laboratories in Taiwan
- 臺灣安寧病房臨床佛教宗教師需求調查
- 臺灣藥學教育的省思與改革
頁籤選單縮合
題 名 | In Vitro Activity of Rifabutin and Rifampin Against Clinical Isolates of Mycobacterium Tuberculosis in Taiwan=臺灣地區臨床檢體分離之結核桿菌對Rifabutin 和 Rifampin 的試管內抗菌力 |
---|---|
作 者 | 簡修平; 余明治; 翁宗輝; 林道平; 陸坤泰; | 書刊名 | 臺灣醫學會雜誌 |
卷 期 | 99:5 2000.05[民89.05] |
頁 次 | 頁408-411 |
分類號 | 414.83 |
關鍵詞 | 臺灣; 臨床; 檢體分離; 結核桿菌; 抗菌力; Mycobacterium tuberculosis; Rifabutin; Rifampin; Multidrug resistance; |
語 文 | 英文(English) |
英文摘要 | Background and purpose: To determine the in vitro activity of rifabutin against Mycobacterium tuberculosis (MTB) and the cross-resistance rate between rifampin and rifabutin. Methods: A total of 56 clinical isolates of MTB, including 23 multidrug-resistant (MDR) isolates and 33 susceptible isolates, were tested for susceptibility to rifampin and rifabutin using the absolute concentration method. The concentrations of drugs tested were 2.5 and 5 mg/mL for rifampin and 0.1, 0.5, 1, 2.5, 5, and 10 mg/mL for rifabutin. Results: All 33 MTB isolates that were susceptible to rifampin were also susceptible to rifabutin. None of the 23 MDR-MTB isolates were inhibited by rifabutin at a concentration of 0.1 mg/mL. Among these 23 MDR isolates, three were susceptible to rifabutin at concentrations 0.5 mg/mL, six were susceptible to rifabutin at concentrations 5 mg/mL, 18 were susceptible to rifabutin at concentrations 10 mg/mL and five were not inhibited at any of the concentrations tested. The cross-resistance rate between rifampin and rifabutin was 87%. Conclusions: Our results indicate that the in vitro activity of rifabutin against drug- susceptible MTB isolates is greater than that of rifampin. For MDR-MTB isolates, the cross-resistance is high between rifampin and rifabutin. |
本系統中英文摘要資訊取自各篇刊載內容。